Compare NABI to:
After Hours:
4.9282
-0.00 (-0.04%) 4:24pm ET
| Last Trade: | 4.93 |
|---|---|
| Trade Time: | Nov 25 |
| Change: | |
| Prev Close: | 4.90 |
| Open: | 4.93 |
| Bid: | N/A |
| Ask: | 6.25 x 600 |
| 1y Target Est: | 7.00 |
| Day's Range: | 4.83 - 4.96 |
|---|---|
| 52wk Range: | 2.15 - 5.30 |
| Volume: | 282,414 |
| Avg Vol (3m): | 293,689 |
| Market Cap: | 250.25M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.33 |
| Div & Yield: | N/A (N/A) |
| Wed 4:21pm | NABI BIOPHARMACEUTICALS Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online |
| Tue, Nov 17 | This Partnership Is Smoking!at Motley Fool |
| Tue, Nov 17 | Nabi Biopharmaceuticals Conference Call to discuss announcement of the exclusive worldwide option and licensing agreement for NicVAX(R) scheduled for 11:00 am ET todayCCBN |
| Tue, Nov 17 | Glaxo and Nabi Team Up for Nicotine Vaccineat Minyanville.com |
| Mon, Nov 16 | [$$] Sonic Solutions, Nabi and Bristow Advanceat The Wall Street Journal Online |
| Mon, Nov 16 | NABI BIOPHARMACEUTICALS Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, FiEDGAR Online |
| Mon, Nov 16 | Nabi soars on Glaxo deal for smoking vaccineat bizjournals.com |
| Mon, Nov 16 | UPDATE - Nabi, Glaxo sign nicotine-addiction vaccine dealat Reuters |
| Mon, Nov 16 | Sprint, CombinatoRx: Early Volume Playsat TheStreet.com |
| Mon, Nov 16 | Nabi Biopharmaceuticals to Hold Conference CallGlobeNewswire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.